轴性脊柱关节炎患者对肿瘤坏死因子抑制剂治疗应答的特征分析
本研究纳入249例基线未使用过生物制剂、因活动性轴性疾病开始首种TNFi治疗的成人轴性SpA患者,按首次TNFi临床应答分为原发无应答(PLR,n=62)、继发无应答(SLR,n=93)和应答者(n=94),分析PLR的独立预测因素。结论为PLR约占TNFi失败的近40%,年龄较大、HLA-B27阴性、基线BASDAI较高及使用可溶性TNF受体蛋白是PLR的独立预测因素。
要点
- 249例轴性SpA患者中PLR 62例、SLR 93例、应答者94例。
- PLR患者年龄较大、HLA-B27阳性率较低、基线BASDAI较高。
- 年龄增大、HLA-B27阴性、基线BASDAI较高及使用可溶性TNF受体蛋白是PLR独立预测因素。
核心结论
- PLR约占轴性SpA患者TNFi失败的近40%。
- 年龄较大、HLA-B27阴性、基线疾病活动度较高及使用可溶性TNF受体蛋白是TNFi原发无应答的独立预测因素。
研究设计与样本
- 研究纳入基线评估时未使用过TNFi、因活动性轴性疾病开始首种生物制剂治疗的成人轴性SpA患者。
- 根据对首次TNFi的临床应答将患者分为PLR、SLR和应答者3组,收集并分析临床、人口学和实验室数据。
- 共纳入249例轴性SpA患者(男性70.7%,平均±SD年龄37.3±12.4岁),包括PLR 62例、SLR 93例和应答者94例。
主要发现
- PLR患者较SLR患者或应答者年龄趋于更大、HLA-B27率更低、无应答轴性SpA患者比例更高、基线BASDAI评分更高。
- 多因素回归分析中,年龄增大、HLA-B27阴性、基线BASDAI较高及使用可溶性TNF受体蛋白是PLR的独立预测因素。
关键数值与推荐
- PLR 62例、SLR 93例、应答者94例,共249例。
- 男性占70.7%,平均±SD年龄37.3±12.4岁。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Lack of response to tumor necrosis factor inhibitor (TNFi) agents is not uncommon, encountered during the treatment of axial spondyloarthritis (SpA) patients, and it can be classified as primary lack of response (PLR) or secondary lack of response (SLR). The primary aim of this study was to evaluate factors associated with TNFi failure types and their characteristics in axial SpA. METHODS: Adult axial SpA patients who were TNFi naive at the time of baseline evaluation and started receiving their first biologics for active axial disease were identified. Based on the clinical response to the first TNFi, patients were then stratified into 3 groups: PLR, SLR, and responders. Clinical, demographic, and laboratory data were collected and analyzed. RESULTS: There was a total of 249 axial SpA patients in the study (70.7% male, mean ± SD age 37.3 ± 12.4 years), which included PLR (n = 62), SLR (n = 93), and responders (n = 94). PLR patients tended to be older, with a lower HLA-B27 rate, a higher percentage of nonresponder axial SpA patients, and a higher baseline Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score compared to SLR patients or responders. In multiple regression analysis, increasing age, negative HLA-B27, higher baseline BASDAI, and treatment with the soluble TNF receptor protein were the independent predictors of PLR. CONCLUSION: PLR accounted for nearly 40% of the TNFi failures in axial SpA patients. Older age, negative HLA-B27, higher baseline disease activity, and treatment with soluble TNF receptors were the independent predictors of the primary nonresponse to TNFi.
引用
- Alazmi M, Sari I, Krishnan B, et al. Profiling Response to Tumor Necrosis Factor Inhibitor Treatment in Axial Spondyloarthritis. Arthritis Care Res (Hoboken). 2018. PMID: 29125891. doi:10.1002/acr.23465
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。